Supernus Pharmaceuticals, Inc.
$SUPN
Public valuation for Supernus Pharmaceuticals, Inc. (SUPN). Fair value, signal, and key metrics — no sign-in required.
Current Price
$41.92
30% Undervalued
Fair Value Estimate
$55
🌱
Growth Stage
Fast-growing but still investing heavily in growth
Analyst Consensus
Target: $60.50
44% higher than current
Key Metrics
Market Cap
$2.4B
Forward P/E
13.3x
Operating Margin
9.3%
Revenue Growth
28.8%
Get free watchlist alerts
Join the waitlist for valuation updates on $SUPN and the rest of your watchlist.
Join the waitlistJoin the waitlist
Stay on this page to join — no sign-in required.